Clinexiz Clinical Research Services Pvt. Ltd. is a specialized Clinical Research Organization (CRO) and Regulatory Affairs Consulting company dedicated to accelerating the development, validation, and commercialization of innovative healthcare products.
We deliver scientifically robust, ethically conducted, and regulatory-compliant clinical research solutions that help organizations generate high-quality clinical evidence and achieve successful market access.
Recognized as a DPIIT Startup India company by the Government of India and Kerala Startup Mission (KSUM), Clinexiz represents a new generation of healthcare innovation partners committed to advancing medical science through research excellence, regulatory expertise, and operational integrity.
Robust, standards-aligned clinical studies
Streamlined pathways to approval
Scalable delivery across India & SEA
Clinexiz delivers end-to-end clinical research solutions across India and SEA countries, aligned with regional regulatory requirements
Read MoreWe conduct clinical investigations and post-market studies of medical devices
Read MoreClinexiz specializes in performance evaluation studies for in-vitro diagnostic (IVD) kits
Read MoreWe provide cosmetic safety and efficacy studies to support regulatory compliance and marketing claims.
Read MoreWe design and execute clinical studies for nutraceutical and dietary supplement products
Read MoreWe provide complete regulatory documentation support for clinical research and performance evaluation submissions.
Read MoreClinexiz conducts Good Clinical Practice (GCP) training programs for investigators, clinical research staff, and organizations.
Read MoreOur services are designed to generate scientifically robust, clinically relevant, and regulatory-acceptable evidence that accelerates product approval and market entry.
Clinexiz delivers high-quality clinical research and regulatory consulting services across India and key Southeast Asian (SEA) countries, supported by a strong network of investigators, laboratories, ethics committees, and regulatory experts.
Read More